Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS), covering 2022-10-27 to 2022-10-27. Get the full timeline:
Most recent: Clinical Trial Update: A 12-Week Treatment Study to Evaluate the Effectiveness of Albuterol Multidose Dry Powder Inhaler With Integrated Electronic Module Digital System (eMDPI DS) in Participants13 Years or Older With Asthma [Phase 4]